Product Details for ANDA 078631
CARBOPLATIN (CARBOPLATIN)
50MG/5ML (10MG/ML)
Marketing Status: Discontinued
150MG/15ML (10MG/ML)
Marketing Status: Discontinued
450MG/45ML (10MG/ML)
Marketing Status: Discontinued
600MG/60ML (10MG/ML)
Marketing Status: Discontinued
50MG/5ML (10MG/ML)
Marketing Status: Discontinued
Active Ingredient: CARBOPLATIN
Proprietary Name: CARBOPLATIN
Dosage Form; Route of Administration: INJECTABLE; INTRAVENOUS
Strength: 50MG/5ML (10MG/ML)
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A078631
Product Number: 001
Approval Date: Dec 2, 2008
Applicant Holder Full Name: PLIVA LACHEMA AS
Marketing Status: Discontinued
Patent and Exclusivity Information
CARBOPLATIN (CARBOPLATIN)
Proprietary Name: CARBOPLATIN
Dosage Form; Route of Administration: INJECTABLE; INTRAVENOUS
Strength: 50MG/5ML (10MG/ML)
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A078631
Product Number: 001
Approval Date: Dec 2, 2008
Applicant Holder Full Name: PLIVA LACHEMA AS
Marketing Status: Discontinued
Patent and Exclusivity Information
150MG/15ML (10MG/ML)
Marketing Status: Discontinued
Active Ingredient: CARBOPLATIN
Proprietary Name: CARBOPLATIN
Dosage Form; Route of Administration: INJECTABLE; INTRAVENOUS
Strength: 150MG/15ML (10MG/ML)
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A078631
Product Number: 002
Approval Date: Dec 2, 2008
Applicant Holder Full Name: PLIVA LACHEMA AS
Marketing Status: Discontinued
Patent and Exclusivity Information
CARBOPLATIN (CARBOPLATIN)
Proprietary Name: CARBOPLATIN
Dosage Form; Route of Administration: INJECTABLE; INTRAVENOUS
Strength: 150MG/15ML (10MG/ML)
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A078631
Product Number: 002
Approval Date: Dec 2, 2008
Applicant Holder Full Name: PLIVA LACHEMA AS
Marketing Status: Discontinued
Patent and Exclusivity Information
450MG/45ML (10MG/ML)
Marketing Status: Discontinued
Active Ingredient: CARBOPLATIN
Proprietary Name: CARBOPLATIN
Dosage Form; Route of Administration: INJECTABLE; INTRAVENOUS
Strength: 450MG/45ML (10MG/ML)
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A078631
Product Number: 003
Approval Date: Dec 2, 2008
Applicant Holder Full Name: PLIVA LACHEMA AS
Marketing Status: Discontinued
Patent and Exclusivity Information
CARBOPLATIN (CARBOPLATIN)
Proprietary Name: CARBOPLATIN
Dosage Form; Route of Administration: INJECTABLE; INTRAVENOUS
Strength: 450MG/45ML (10MG/ML)
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A078631
Product Number: 003
Approval Date: Dec 2, 2008
Applicant Holder Full Name: PLIVA LACHEMA AS
Marketing Status: Discontinued
Patent and Exclusivity Information
600MG/60ML (10MG/ML)
Marketing Status: Discontinued
Active Ingredient: CARBOPLATIN
Proprietary Name: CARBOPLATIN
Dosage Form; Route of Administration: INJECTABLE; INTRAVENOUS
Strength: 600MG/60ML (10MG/ML)
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A078631
Product Number: 004
Approval Date: Dec 2, 2008
Applicant Holder Full Name: PLIVA LACHEMA AS
Marketing Status: Discontinued
Patent and Exclusivity Information
Proprietary Name: CARBOPLATIN
Dosage Form; Route of Administration: INJECTABLE; INTRAVENOUS
Strength: 600MG/60ML (10MG/ML)
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A078631
Product Number: 004
Approval Date: Dec 2, 2008
Applicant Holder Full Name: PLIVA LACHEMA AS
Marketing Status: Discontinued
Patent and Exclusivity Information